Clinical trial
Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification
NCT02799173 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 15, 2011
- Completion date
- July 1, 2015
- Enrollment
- 74 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.